Palisade Bio, Inc. (PALI)
NASDAQ·Healthcare·Biotechnology
$2.06
+3.23%
Mkt Cap $357.57M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$4.50
Range $2.00 – $7.00
Implied Upside
+118.4%
Consensus $4.50 vs current $2.06
NASDAQ·Healthcare·Biotechnology
$2.06
+3.23%
Mkt Cap $357.57M
No recent rating data.
Price Target (3 analysts)
$4.50
Range $2.00 – $7.00
+118.4%
Consensus $4.50 vs current $2.06